Computational immunology is an interdisciplinary field that leverages computational and mathematical approaches to analyze complex immune system dynamics, understand immunological processes, and predict immune responses. This field plays a crucial role in advancing our understanding of immune system function, host-pathogen interactions, and the development of immune-related disorders. Using computational models, bioinformatics, and data-driven techniques, computational immunologists analyze large-scale biological data, such as genomics, proteomics, and high-throughput sequencing data. These approaches help identify patterns, pathways, and potential biomarkers associated with immune responses and diseases. Computational immunology contributes to vaccine design, drug development, and personalized medicine by simulating immune responses, predicting antigen-antibody interactions, and optimizing treatment strategies. Machine learning and artificial intelligence techniques are increasingly employed to analyze complex immunological datasets and make predictions. This field also facilitates the integration of diverse data sources, aiding in the discovery of novel immunological insights. Computational models help simulate immune responses in various scenarios, contributing to our ability to understand and predict the outcomes of different immunotherapies. As computational immunology continues to evolve, it serves as a powerful tool for unraveling the intricacies of the immune system, accelerating discoveries in immunological research, and informing the development of innovative strategies for diagnosing and treating immune-related disorders.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States